Dr. Yvonne Adeduni Efebera, MD, MPH

Expert Publications

• Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma.
• Circulating miRNA markers show promise as new prognosticators for multiple myeloma.
• It is time to move forward with Waldenström!
• Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant.
• The Impact of Pre-Stem Cell Transplant Ferritin Level on Late Transplant Complications: An Analysis to Determine the Potential Role of Iron Overload on Late Transplant Outcomes.
• Long-Term Therapy with Lenalidomide in a Patient with POEMS Syndrome.
• Tocilizumab for steroid refractory acute graft-versus-host disease.
• Renal Amyloidosis Associated With 5 Novel Variants in the Fibrinogen A Alpha Chain Protein.

Clinical Trials

• Lenalidomide and Nivolumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
• Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease
• Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease
• Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65

Media Releases

Get to know Hematologist-Oncologist Dr. Yvonne Adeduni Efebera, who serves patients in Columbus, Ohio.

Dr. Efebera is a highly trained hematologist-oncologist who specializes in B-cell lymphoid malignancies, including multiple myeloma, amyloidosis, Waldenstrom’s disease, and stem cell and bone marrow transplant. She is an international leader focusing her clinical and research expertise in blood and marrow transplantation, multiple myeloma, and plasma cell dyscrasia.

In association with OhioHealth Physician Group Medical Oncology and Hematology (Columbus Bing Cancer Center Ste 2E), she is the Director of Blood and Marrow Transplant and Cellular Therapy for OhioHealth. She is also active at OhioHealth Riverside Methodist Hospital.

Back in 1998, Dr. Efebera graduated with her medical degree from Pennsylvania State University College of Medicine. She then went on to perform her residency in internal medicine at Cleveland Clinic in 2001, her fellowship in hematology/oncology at Boston Medical Center in 2005, and her fellowship in bone marrow transplant at University of Texas MD Anderson Cancer Center in 2009.

Subsequent to her education, she attained board certification in medical oncology and internal medicine through the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Among her professional affiliations, Dr. Efebera is an active member of the American College of Physicians and the American Society of Clinical Oncology.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, and sickle-cell disease.

Dr. Efebera has been named “TOP Doctors”, “Regional Top Doctors”, “MOST Honored Doctor”, and “Exceptional Women in Medicine” since 2016 by Castle Connolly. She has also been rated in the top ten percent of physicians in the nation for patient satisfaction since 2014. 

Recommended Articles

• What Is Porphyria?

  Porphyria is an inherited group of disorders that affect the skin and nerves. Porphyria that affects the skin is referred to as cutaneous porphyria, while the condition that affects the nerves is known as acute porphyria. Both types result in the accumulation of the chemical porphyrin in the body....

• What Is Thalassemia Intermedia?

  Thalassemia intermedia is an inherited genetic blood disorder. It is a milder form of thalassemia, wherein there is a reduced production of “adult” hemoglobin, which leads to anemia. It means that your child has a missing ingredient to create a normal adult hemoglobin.Thalassemia intermedia is...

• Lymphoma GoFundMe Success Stories

  When a community or group of friends bands together to help one another, miracles happen. There is nothing more humbling than seeing a community take time of their own to help a friend or community member in need. The more people there are, the bigger difference they can make. There are hundreds of...

• What Causes Anemia?

  Anemia is a condition characterized by low levels of red blood cells, or hemoglobin. This results in cells of the body receiving insufficient amounts of oxygen. The tissues and organs and do not function properly resulting in tiredness. It is one of the most common conditions seen in people, and it...

• Different Types of Physicians Explained

  Doctors or physicians are categorized according to different factors including medical specialties and subspecialties. Most doctors specialize in a specific area of medicine. This article provides a summary of the different types of doctors in the medical field. AllergistsAllergists are also...

• Anemia: Psychological Approach to Patients

  The complete working of the human brain has been explained by numerous psychologists in the world. They have spent their lives trying to find the relation between different problems and how they affect the working of the human brain. The sanctioning of this relation is key to understanding why even...